Antioxidants (May 2022)

Caudal–Rostral Progression of Alpha Motoneuron Degeneration in the SOD1<sup>G93A</sup> Mouse Model of Amyotrophic Lateral Sclerosis

  • Alastair J. Kirby,
  • Thomas Palmer,
  • Richard J. Mead,
  • Ronaldo M. Ichiyama,
  • Samit Chakrabarty

DOI
https://doi.org/10.3390/antiox11050983
Journal volume & issue
Vol. 11, no. 5
p. 983

Abstract

Read online

Mice with transgenic expression of human SOD1G93A are a widely used model of ALS, with a caudal–rostral progression of motor impairment. Previous studies have quantified the progression of motoneuron (MN) degeneration based on size, even though alpha (α-) and gamma (γ-) MNs overlap in size. Therefore, using molecular markers and synaptic inputs, we quantified the survival of α-MNs and γ-MNs at the lumbar and cervical spinal segments of 3- and 4-month SOD1G93A mice, to investigate whether there is a caudal–rostral progression of MN death. By 3 months, in the cervical and lumbar spinal cord, there was α-MN degeneration with complete γ-MN sparing. At 3 months, the cervical spinal cord had more α-MNs per ventral horn than the lumbar spinal cord in SOD1G93A mice. A similar spatial trend of degeneration was observed in the corticospinal tract, which remained intact in the cervical spinal cord at 3- and 4- months of age. These findings agree with the corticofugal synaptopathy model that α-MNs and CST of the lumbar spinal cord are more susceptible to degeneration in SOD1G93A mice. Hence, there is a spatial and temporal caudal–rostral progression of α-MN and CST degeneration in SOD1G93A mice.

Keywords